Real-Time MRI-Guided Prostate Interventions

Journal: Cancers (Basel).
Year of publication: 2022
Page: 14(8):1860

S.N. Masoom, K.M. Sundaram, P. Ghanouni, J.J. Fütterer, A. Oto, R. Ayyagari, P. Sprenkle, J. Weinreb & S. Arora

Prostate cancer (PCa) is the second most common cause of cancer death in males. Targeting MRI-visible lesions has led to an overall increase in the detection of clinically significant PCa compared to the prior practice of random ultrasound-guided biopsy of the prostate. Additionally, advances in MRI-guided minimally invasive focal treatments are providing new options for patients with PCa. This review summarizes the currently utilized real-time MRI-guided interventions for PCa diagnosis and treatment.